Cell to Cure ApS
Clinical-stage biopharmaceutical company developing off-the-shelf mesenchymal stem cell therapies for regenerative medicine.
Overview
- 14
- Employees
- Unknown
- Revenue
- 2018
- Founded
Key Decision Makers
Jens Kastrup
CEO & Clinical Director
Anders Østergaard
Chairman of the Board
Annette Ekblond
Director of Product Development & Qualified Person
Mandana Haack-Sørensen
Director of Manufacturing
+1 more contacts in Funnelfeedr
Description
Cell to Cure ApS is a Danish clinical-stage biopharmaceutical company specializing in the development of allogeneic adipose tissue-derived mesenchymal stromal/stem cell therapies. Founded as a spinout from the Cardiology Stem Cell Centre at Rigshospitalet, the company focuses on creating off-the-sh...